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Induction of Nitric Oxide in Human Keratinocytes
in vitro
Yaping E.1, Samantha C. Golden1, Alan R. Shalita1, Wei-Li S. Lee1, Daniel H. Maes2 and Mary S. Matsui2
Nitric oxide (NO) is an important signaling molecule in both the central nervous system and the periphery,
where it is involved in neurotransmission, vascular and bronchial tone, inflammation, and cutaneous immune
function. More recently, NO has been implicated in intracellular signaling and may have a role in cellular
differentiation, cytokine expression, and apoptosis. The experiments described herein examined the effect of
calcitonin gene-related protein (CGRP), a cutaneous nerve neuropeptide, on NO production in human
keratinocytes in vitro. CGRP stimulated two distinct increases in NO production: one within 30 minutes and a
second at 24 hours. CGRP stimulated a modest increase in inducible nitric oxide synthase (iNOS) at 3–6 hours.
Experimental evidence suggested that CGRP stimulated both constitutive NOS activity and generation of NO via
nitrosothiol degradation within the first hour. Production of NO was paralleled by a decrease in nitrosothiol
levels for 2 hour, suggesting that immediate NO release may originate from pre-existing stores. Nitrosothiols are
ubiquitous molecules that comprise an important NO pool and have intracellular regulatory roles, particularly
linked to oxidative stress. The present data indicate that, in addition to its known cAMP signaling pathway, CGRP
may act to regulate keratinocyte biology through intracellular NO by modulation of S-nitrosothiol stores and
stimulation of NOS activity.
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INTRODUCTION
A wide range of pro-inflammatory stimuli can induce the
release of neuropeptides from cutaneous sensory nerves,
including heat, physical trauma, UVR, and irritant chemicals.
The release of these neuropeptides can then lead to
neurogenic inflammation with erythema and edema. These
pro-inflammatory stimuli are known to induce the release of
calcitonin gene-related peptide (CGRP), one of the principal
mediators of neurogenic inflammation, from cutaneous
sensory nerves (Seike et al., 2002). In addition, CGRP has
been associated with psychological stress-induced cutaneous
neurogenic inflammation (Harvima et al., 1993).
The effect of CGRP on Langerhans cells has been well
characterized (Torii et al., 1997), but its effect on epidermal
keratinocytes has been less thoroughly studied. The presence
of CGRP-specific membrane receptors on keratinocytes that
modulate keratinocyte biology is well established. For
example, CGRP receptors in human keratinocytes modulate
proliferation through stimulation of cAMP formation (Taka-
hashi et al., 1993). In addition, CGRP stimulation of
proliferation has been shown to be important for wound
healing (Hsieh et al., 1996). Elevation of CGRP levels have
been associated with epidermal hyperproliferation (Jiang
et al., 1998; Seike et al., 2002; for a review see Seiffert and
Granstein, 2002). Furthermore, it has also been shown that
CGRP can regulate the production of specific cytokines and
their receptors in skin, although few studies have looked
directly at CGRP-induced cytokine expression in keratino-
cytes (Kiss et al., 1999). One important role of CGRP in
dermal microvascular endothelial cells is the induction of
nitric oxide (NO) production by activation of a constitutive
endothelial NOS (eNOS) (Bull et al., 1996), but this
parameter has not been studied in epidermal keratinocytes.
If CGRP induces NO in keratinocytes, it would serve as a
separate source of NO distinct from NO co-released with
CGRP from sensory nerves upon irradiation of skin, and
might have additional and separate effects on keratinocyte
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biology, including such diverse events as apoptosis and
proliferation necessary for wound healing. Exposure of
epidermal keratinocytes to UVR has been shown to induce
NO, both by upregulation of inducible nitric oxide synthase
(iNOS) (Weller et al., 2002) and from activation of Ca2þ /
calmodulin-dependent particulate NO synthase (constitutive
NOS, cNOS) (Deliconstantinos et al., 1995, 1996). The effect
of CGRP on these same phenomena in human keratinocytes
is not known. We therefore asked if CGRP is able to induce
NO production in human epidermal keratinocytes. NO
production may result from an increase in iNOS expression,
an increase in cNOS activity, or release of NO from
S-nitrosothiols. We examined the effect of CGRP on these
three sources.
RESULTS
CGRP-induced NO production in hTERT keratinocytes
Cells were treated with media containing CGRP (0, 0.1, 1, 10
and 100 nM), harvested at various time points (0.25, 0.5,
1 hour, 1.5, 2, 3, 6, 12, 24, and 48 hours) without further
changing the media, and the intracellular NO content was
determined (Figure 1). Refeeding alone stimulated a brief
burst of NO production in keratinocytes that resolved by
6 hours. Therefore, data from CGRP-treated groups is
expressed as fold change from vehicle control. CGRP began
to induce higher levels of NO than vehicle control at
30 minutes, and induced 3- to 4.5-fold higher levels by
1 hour. Intracellular NO decreased sharply by 3 hours to
approximately control levels at 6 hours. At 24 hours, NO was
again significantly elevated (3- to 6-fold) for all CGRP
concentrations. By 48 hours after initiation of CGRP treat-
ment, NO levels in the treated groups were the same as
control. Under the same conditions, this phenomenon was
observed in normal human keratinocytes (NHEKs) (Figure 1,
inset) and is described below (Effect of CGRP on normal
human epidermal keratinocytes).
In order to show that induction of NO by CGRP occurred
through a specific CGRP receptor-mediated mechanism, cells
were treated with CGRP in the presence or absence of
CGRP8-37, which has been shown to block CGRP receptor
interaction (Parameswaran et al., 2000). In these experi-
ments, CGRP8-37 behaved like a weak agonist with a
temporal pattern of NO induction similar to CGRP, inducing
approximately a 1.6-fold increase in NO at 1 hour and
24 hours (Figure 1). The magnitude of CGRP8-37-induced
NO was significantly less than CGRP-induced NO. In the
presence of 100 nM CGRP8-37, 100 nM CGRP-induced NO
levels at 1 hour were significantly depressed compared to
cells treated with 100 nM CGRP alone. These results show
characteristics of a competitive antagonist and suggest that
CGRP may act through a specific receptor. Further experi-
ments were performed to examine the effect of CGRP8-37 in
cells treated with lower concentrations of CGRP (Table 1). At
1 hour, NO production in cells treated with 0.1, 1, and 10 nM
CGRP was suppressed by CGRP8-37. At 24 hours, NO
production induced by 1 and 10 nM CGRP continued to be
suppressed by the antagonist. There was no statistically
significant difference between 0.1 nM CGRP and 0.1 nM
CGRPþCGRP8-37 at 24 hours. Cells treated with CGRP8-
37 alone showed some induction of NO, and therefore the
inhibition was incomplete. Maximum inhibition of CGRP-
induced NO was approximately 30–40%.
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Figure 1. Time course of NO production by keratinocytes stimulated with CGRP. hTERT cells are shown as the primary graph and NHEK are shown as an inset.
Average fold change values from five (hTERT) or three (NHEK) separate and independent experiments were combined. Cells either served as vehicle control
or were treated with either (}) UVB, (&) 0.1 nM, (n) 1 nM, (X) 10 nM, (*) 100 nM CGRP, (J) 100 nM CGRP8-37, or (þ ) 100 nM CGRP8-37þ 100 nM CGRP,
and were harvested at 0.25, 0.5, 1 hour, 1.5, 2, 3, 6, 12, 24, and 48 hours. Intracellular NO levels were determined by FACS analysis, and values are shown
as average fold change from vehicle control. Error bars represent the SD. Cellular NO content of vehicle-treated cells was also determined by Greiss
assay and ranged from 5.09 to 9.90 mM. Student’s t-test was used to determine significance, and *Po0.05 compared to the vehicle control. CGRP did not alter
keratinocyte apoptosis or cytotoxicity.
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CGRP induction of NOS protein
CGRP concentrations of 1 and 10 nM induced modest, but
statistically significant increases in iNOS protein levels at
6 hours (Figure 2). Six hours after initiating CGRP treatment (1
and 10 nM), iNOS protein was approximately 1.5-fold that of
vehicle control. There was no significant increase in iNOS
protein at the lowest concentration of CGRP (0.1 nM). At 24
and 48 hours, there was no difference in iNOS levels between
any treatment groups. Overall, there was not a robust
increase of iNOS protein expression in human telomerase
reverse transcriptase (hTERT) keratinocytes during the time
period tested. In similar experiments, UVB, in contrast to
CGRP, induced a significant increase in iNOS levels by
6 hours (Matsui et al., 2003). The presence of eNOS protein
was verified, but as expected, CGRP did not alter levels of the
constitutive NOS protein (data not shown).
Effect of NOS inhibitors on CGRP-induced NO
To determine the effect of blocking NOS on CGRP-induced
NO, cells were incubated with NOS inhibitor alone or CGRP
in the presence or absence of inhibitor (Table 1). There was
no cytotoxicity at 24 hours for any treatment. NO was
assayed at 30 minutes, 1 hour, and 24 hours post-treatment
for three concentrations of CGRP (0.1, 1, and 10 nM) in the
presence or absence of inhibitor. Neither eNOS nor iNOS
inhibition significantly suppressed CGRP-induced NO pro-
duction at 30 minutes. At 1 hour, suppressing eNOS resulted
in a significant decrease in NO production by CGRP (1 and
10 nM)-treated cells. At 24 hours, NG-nitro-L-arginine (L-NNA)
significantly suppressed NO production at all concentrations
of CGRP tested. Pretreatment of cells with 1400W (N-(3-
aminomethyl)benzylacetamidine, 2HCl) (20 nM) also had no
effect at 30 minutes on cells treated with CGRP, but at 1 hour
and 24 hours appeared to have inconsistent effects or to
increase NO production. The overall results indicated that
Table 1. Effect of UVB, CGRP, and CGRP in the presence of inhibitors of NO production in hTERT keratinocytes:
mean fold change in NO production7SD over time
Incubation time
Treatment 30 minutes 1 hour 24 hours
CGRP 0.1 nM 2.3970.071,* 4.9170.101,** 3.5870.081,**
CGRP 1 nM 2.4170.081,* 6.0470.121,** 4.7970.121,**
CGRP 10 nM 2.6970.051,** 6.4970.121,** 5.6870.111,**
CGRP8-37 100 nM 2.5570.044 2.0370.112,** 3.570.142,**
CGRP 0.1 nM+CGRP8-37 100 nM 2.6670.1 4.2470.073,* 3.2770.023,**
CGRP 1 nM+CGRP8-37 100 nM 2.5870.3 3.9670.024,** 3.0570.054,**
CGRP 10 nM+CGRP8-37 100 nM 2.5570.5 3.9970.032,** 3.6170.042,**
CGRP 0.1 nM+L-NNA 200 nM 2.2370.05 5.6170.123,* 2.8270.073,**
CGRP 1 nM+L-NNA 200 nM 2.8470.06 5.5970.144,* 3.9770.084,*
CGRP 10 nM+L-NNA 200 nM 2.6070.09 5.7170.152,* 3.0270.052,**
CGRP 0.1 nM+1400W 20 nM 2.4070.04 5.3870.14 6.0670.103,**
CGRP 1 nM+1400W 20 nM 2.5570.04 5.1670.124,** 6.2570.054,*
CGRP 10 nM+1400W 20 nM 2.9570.06 6.1970.21 7.6970.082,**
Data shown as fold increase or decrease, means of triplicate determinations7SD.
1Paired t-test compared with vehicle control.
2Paired t-test compared with CGRP 10.0 nM.
3Paired t-test compared with CGRP 0.1 nM.
4Paired t-test compared with CGRP 1.0 nM.
*Pp0.01, **Pp0.001.
0
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
1.60
1.80
2.00
5
Fo
ld
 c
ha
ng
e 
fro
m
 ve
hi
cl
e 
co
nt
ro
l
10 15 20 25
Time (hours)
30 35 40 45
CGRP 0.1 nM
CGRP 1 nM
CGRP 10 nM
50
*
*
Figure 2. Effect of CGRP on iNOS level in hTERT keratinocytes. Cells were
treated with either (vehicle control) 0, (}) 0.1 nM, (&) 1 nM, or (n) 10 nM
CGRP for 1 hour, 3, 6, 12, 24, and 48 hours. iNOS levels were measured by a
colorometric ELISA and expressed as fold change from vehicle control. Data
are the means of triplicate determinations7SD; *Po0.05 compared with
vehicle control.
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suppression of constitutive NOS had no effect on CGRP-
induced NO production until 1 hour post-treatment, at which
time it significantly decreased NO.
Effect of CGRP on NOS activity
It has been reported that UVB irradiation of keratinocyte
membranes results in the activation of constitutive NOS
within 1 hour (Deliconstantinos et al., 1996). To ascertain
whether CGRP would induce a similar effect, specific activity
of cellular NOS activity was determined at 30 and 60 minutes
after treatment (Figure 3). At 30 minutes, the increase in
activity was statistically significant in all groups treated with
CGRP but not in the UVB-irradiated cultures. At 60 minutes,
both the UVB-treated cultures as well as the CGRP-treated
cultures demonstrated statistically significant increases in
synthase activity.
Effect of CGRP on cellular S-nitrosothiol levels
CGRP treatment of keratinocytes stimulated NO production
within 1 hour that was greater than 2.5-fold when compared
to vehicle control. This magnitude change in NO could not
be completely accounted for by an increase in specific
activity of NOS. Therefore, we looked at the effect of CGRP
on cellular S-nitrosothiol levels, another potential source of
NO. S-nitrosothiol levels in hTERT cells were decreased
within 15 minutes of exposure to CGRP (100 nM) (Figure 4).
The levels of S-nitrosothiols remained significantly decreased
for at least 2 hours. This decrease was seen only in the first
2–3 hours. By 3 hours, there was no significant difference
between any experimental groups, except for the highest
concentration of CGRP (100 nM). Treatment with CGRP8-37
partially blocked the CGRP-induced decrease in nitrosothiol
levels. Differences between the CGRP (0.01–100 nM) treat-
ment groups were not statistically significant, except at
3 hours. A similar phenomenon was seen in NHEKs, as
described below.
Effect of CGRP on normal human epidermal keratinocytes
Preliminary experiments were performed with NHEK to
ascertain whether the same response occurred in primary
keratinocytes. NO production was stimulated by CGRP
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Figure 3. Effect of CGRP or UVB on NOS activity. Cells were treated as
indicated, harvested 30 or 60 minutes later, and NOS activity in whole-cell
lysate determined. Error bars show SD, *indicates a significant increase, and
Po0.05, compared with the vehicle control. Each data point is the average of
duplicate determinations from three independent experiments (six total
determinations).
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Figure 4. Effect of CGRP or UVB on S-nitrosothiol levels in hTERT keratinocytes. hTERT cells are shown as the primary graph and NHEK are shown as an inset.
Average fold change values from five (hTERT) or three (NHEK) separate and independent experiments were combined. Cells either served as vehicle control
or were treated with either (}) UVB, (&) 0.1 nM, (n) 1 nM, (X) 10 nM, (*) 100 nM CGRP, (J) 100 nM CGRP8-37, or (þ ) 100 nM CGRP8-37þ 100 nM CGRP,
and were harvested at 0.25, 0.5, 1 hour, 1.5, 2, 3, 6, 12, 24, and 48 hours. S-nitrosothiol levels were determined by a fluorimetric method. SD are shown,
and *Po0.05 compared to vehicle control.
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(Figure 1, inset) in the same temporal pattern as hTERT cells,
and the NO increase in NHEK was almost as robust as that
seen in hTERT cells. S-nitrosothiol levels showed a dose-
related decrease at time points of 0.25, 0.5, 1 hour, 1.5, and
2 hours (Figure 4, inset). S-nitrosothiol levels continued to be
decreased at 3 hours and thereafter levels for the CGRP-
treated groups remained the same as the vehicle-treated
group.
Exposure of cells to CGRP in the presence of CGRP8-37
inhibited the response (the increase in NO and the decrease
in S-nitrosothiols) by approximately 30–50% (Figures 1 and 4,
Table 1). Complete inhibition was not possible as CGRP8-37
appeared to be a weak agonist in this system, and so a higher
inhibitor to agonist ratio was not more effective.
DISCUSSION
We have shown in this series of experiments that CGRP, a
neuropeptide known to be released from cutaneous nerves, is
capable of inducing NO production in human epidermal
keratinocytes. The data presented herein suggest that the
source of this NO is from two mechanisms: (a) increased
specific NOS activity and (b) decomposition of cellular
S-nitrosothiols.
To our knowledge, this is the first report that demonstrates
CGRP-induced NO production in human epidermal kerati-
nocytes. Within the first hour after exposure to CGRP,
intracellular NO levels increased, cellular NOS specific
activity increased, and intracellular S-nitrosothiol levels
decreased, suggesting that the source of NO could be from
a combination of constitutive NOS activation and release of
NO from intracellular S-nitrosothiol compounds. NOS
inhibitors L-NNA and 1400W were not able to suppress
substantially the NO production in the first one-half hour of
CGRP treatment, which would further indicate that the
CGRP-induced increase in NO was, at least in part, from a
non-NOS mechanism. Interpretation of studies employing
NOS inhibitors are problematic, however, as transient
increases in NO-related products have been reported in
response to NOS inhibition (Bryan et al., 2004).
Activation of constitutive NOS as a possible source for NO
production was examined here because UVB-induced NO
production by cultured human keratinocytes has been shown
to result from Ca2þ /calmodulin-dependent particulate cNOS
activation (Deliconstantinos et al., 1995, 1996). Delicon-
stantinos et al. (1996) suggested that cNOS production of NO
acts as an autocoid in keratinocytes to control proliferation by
inhibiting ribonucleotide reductase, mitochondrial respira-
tion, and DNA synthesis. The present study confirmed
previous observations that UVB triggers NOS activity within
1 hour. We show that CGRP is also capable of stimulating an
increase in NOS activity as early as 30 minutes.
We observed a modest increase in iNOS expression at 6
and 48 hours after treatment of cells with CGRP. This was
similar to the response reported for UVB in NHEK (Seo et al.,
2002). However, iNOS did not appear to be a significant
source for CGRP-induced NO in human keratinocytes; first,
the increase in iNOS did not correlate either in terms of
magnitude or time frame to NO production; and second,
inhibition of iNOS by 1400W was not able to suppress the
increase in NO that occurred within the first hour after CGRP
treatment.
Non-enzymatic sources of NO may more important than
believed previously. Although NO, a free radical gas, is
usually referred to as a product synthesized by NOS from L-
arginine, molecular oxygen, and reduced nicotinamide
adenine dinucleotide phosphate, there are other sources of
biologically active NO in cells. The bioavailability of NO is
regulated not only by the rate of synthesis and breakdown but
also by its interaction with other molecules such as albumin,
glutathione, homocysteine, and cysteine that contain func-
tional sulfhydryl groups (Massy et al., 2003). These resulting
S-nitrosothiols are found in vivo in less than 1 mM concentra-
tions function as a dynamically regulated reservoir of NO
coupled to cell signaling pathways and control mechanisms
(Mannick et al., 1999).
It has recently become clear that S-nitrosylation may be a
central biological signaling mechanism (Bryan et al., 2004).
NO released from intracellular S-nitrosothiols could act as a
signaling molecule by at least two mechanisms: first, by
binding to and activating a soluble guanylate cyclase, thereby
increasing cGMP, and second, by reversibly inhibiting
enzymes such as ribonucleotide reductase, catalase, aconi-
tase, and cytochrome P450. Bernassola et al. (1999) reported
that NO, via S-nitrosylation of thiol groups, can regulate
transglutaminases, a class of enzymes critical in keratinocyte
differentiation. In one study, NO regulated not only
transglutaminases by S-nitrosylation but also the expression
of transglutaminase 1, involucrin, and loricrin by inhibiting
the DNA-binding activity of activator protein-1 (Rossi et al.,
2000).
A more recent report with direct relevance to the present
study was published in which UVA irradiation of ex vivo
human skin was shown to induce NO formation through an
NOS-independent pathway (Paunel et al., 2005). As in our
study, decomposition of nitroso compounds was fast and led
to a high brief burst of NO, during which depletion of the
nitroso species could be measured. The authors further state
that the biological relevance of the non-enzymatic formation
of NO equivalents appears to be an important function in
human skin in which non-enzymatic NO formation occurs
during the lag time before iNOS generation of NO after the
initiating stimulus. This non-enzymatic NO may be involved
in the protection against reactive oxygen species-induced cell
death.
Previous reports from in vivo experiments have used
NG-nitro-L-arginine methyl ester or other NOS inhibitors
to determine whether CGRP (Gangula et al., 2003; Klede
et al., 2003) operates through NO. The present studies
suggest that this paradigm may warrant re-examination owing
to the potential contribution of S-nitrosothiols and activation
of cNOS. The effect of NOS inhibition on a measured end
point will only account for that portion of NO contributed
by the NOS pathway. Bull et al. (1996) suggest that in
human skin, CGRP-induced vasodilation is mediated by
NO-dependent mechanisms and also by NO-independent
mechanisms.
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Further studies are warranted to examine the implications
of signaling by S-nitrosothiols in keratinocytes. It may also be
of interest to determine whether non-enzymatic antioxidants,
such as ascorbic acid and a-tocopherol, interact with CGRP-
induced release of NO, as they catalyze the decomposition of
S-nitrosothiols (Van der Vliet et al., 1997).
Preliminary studies performed in NHEK indicate that
CGRP stimulates NO production in these cells and
that CGRP treatment of primary keratinocytes results in
decreased S-nitrosothiol levels as well. The magnitude of
the NO increase was slightly less robust than in hTERT
cells. Additional studies using normal keratinocytes and
explant tissue are required to assess how relevant the
overall observations are in vivo, and whether immortalization
has conferred increased sensitivity of hTERT keratinocytes
to CGRP. Further studies are in progress to determine
whether CGRP-induced changes in NO, activation of
cNOS, and degradation of S-nitrosothiols can be correlated
to functionally relevant processes such as differentiation
and the expression of transglutaminase 1, involucrin, and
loricrin.
In summary, this study has made two key observations
using human keratinocytes: first, that a neuropeptide, CGRP,
can modulate intracellular levels of NO, and second, that at
least in part, the source for the intracellular NO is non-
enzymatic degradation of S-nitrosylated species. An appre-
ciation of these additional sources and stimuli for cellular NO
in keratinocytes may lead to the development of new
materials designed to block UV-damaging effects such as
immune suppression and photoaging. It may also expand our
understanding of how neuropeptides regulate wound healing,
cellular proliferation, and apoptosis.
MATERIALS AND METHODS
Chemicals
CGRP, CGRP8-37, (6R)-5,6,7,8-tetrahydrobiopterin, flavin adenine
dinucleotide, ethyleneglycol-bis(b-aminoethyl ether)-N, N, N0, N0-
tetraacetic acid CaCl2, calmodulin, L-arginine, and N-2-hydro-
xyethylpiperazine-N0-2-ethanesulfonic acid were obtained from
Sigma Chemical Co. (St Louis, MO), and L-NNA 1400W from
EMD Biosciences, Inc. (San Diego, CA). NO FACS analysis reagents
were purchased from Clontech Laboratories Inc., (Palo Alto, CA).
Human iNOS and eNOS ELISA kits were purchased from R&D
Systems (Minneapolis, MN). Additional reagents included Dowax
AG 50W-X8 resin (Naþ form) (Bio-Rad, Richmond, CA) and
L-[U-14C]L-arginine (Amersham, Piscataway, NJ).
L-NNA is a relatively selective eNOS inhibitor with a Ki of 90 nM
(compared to a Ki for iNOS of 8.1 mM). 1400W is a relatively
selective iNOS inhibitor that exhibits greater than 5000- and 200-
fold potency against human iNOS relative to eNOS and nNOS,
repectively (Reif and McCreedy, 1995; Parmentier et al., 1999).
Cell culture
hTERT human keratinocytes were a generous gift of J.P. Rheinwald
and were grown in M154 keratinocyte growth medium (EpiLife;
Cascade Biologics, Portland, OR) in a 5% CO2 incubator. This
keratinocyte cell line was transduced with telomerase and contains
deletions of the CDK2N/INK4a locus (Dickson et al., 2000).
Transduction of telomerase alone incompletely rescues them from
senescence, so the immortal clones also contain a deficiency in the
cell cycle control mechanism coded by pRB/p16(INK4a). The cells
differentiate normally upon Ca2þ stimulation.
Normal human keratinocytes were purchased from Cascade
Biologics Inc. (Portland, OR) and grown as specified. Cells
were used within three passages. Keratinocytes were plated
at a density equivalent to 106 cells/10-cm2 tissue culture dish. The
medium was removed 24 hours later, cells were rinsed with
phosphate-buffered saline, and re-fed with hydrocortisone-free
keratinocyte growth medium containing 200mM L-arginine and
200mM L-glutamine.
When the cells reached 70–75% confluence, cell culture medium
was removed and replenished with fresh hydrocortisone-free
keratinocyte growth medium containing 200mM L-arginine and
200mM L-glutamine medium in which CGRP was added at the
concentrations indicated in Results. Hydrocortisone was removed
because it has been reported to suppress expression of iNOS (Frank
et al., 2000). In some experiments, the CGRP receptor antagonist
CGRP8-37, or the NOS inhibitors L-NNA and 1400 W, were added
at concentrations indicated in Results for 30 minutes before adding
CGRP. In the latter experiments, CGRP was added to cultures
without replenishing the media. Cells were incubated for the length
of time indicated in Results before harvesting for NO, NOS, and
S-nitrosothiol level measurements. CGRP, CGRP8-37, L-NNA, and
1400W were used at concentrations below cytotoxicity.
For experiments in which cells were irradiated with UVB, using a
Spectroline EB-160C (Fisher Scientific Company, Hampton, NH)
lamp with a wavelength maximum at 312 nM, cell culture medium
was removed when the culture was 90–95% confluent, cells were
rinsed, and covered with a thin layer of Hank’s balanced salt
solution (HBSS) with no phenol red. Cells were then exposed to
30 mJ/cm2 UVB radiation as in Results. After treatment, hydro-
cortisone-free, arginine, and glutamine-supplemented keratinocyte
growth medium was added for the indicated length of incubation
before harvesting for analysis of NO, NOS, and S-nitrosothiol levels.
For all experiments, viability of cells was determined. Cells were
treated with 1 mg/ml 3-(4,5-dimerthylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide in HBSS for 30 minutes at 371C, 5% CO2. The
3-(4,5-dimerthylthiazol-2-yl)-2,5-diphenyltetrazolium bromide solu-
tion was removed from the surface of the cells and dimethyl
sulfoximine added. The absorbance of the resultant solution was
measured at 550 nM and treated cells were compared with untreated
or vehicle-treated control cells.
Measurement of NO
NO oxide production by keratinocytes was measured with an
ApoAlert Nitric oxide/Annexin V Dual Sensor kit (Clontech
Laboratories Inc.) according to the instructions given by the
manufacturer (CLONTECHniques XVI, 1:24–25, 2001). In brief,
3ml of NO sensor dye was added to subconfluent hTERT cells and
incubated at 371C, 5% CO2 for 30 minutes. The cells were treated
with UVB, CGRP, CGRP8-37, L-NNA, and 1400W for the time
periods specified in Results, upon which cells were harvested and
subjected to 400 g. The cell pellet was resuspended with 500 ml
HBSS and fluorescence measured by flow cytometry analysis (FACS),
using a Becton Dickinson FACScan instrument. For every experi-
ment, the fluorescence value of each sample was determined and
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then compared to vehicle control fluorescence values. The sample
data was then expressed as fold change from control. Triplicate
sample fold change values were averaged and expressed as
mean7SD.
Because FACS analysis provides only relative levels of NO, NO
production of hTERT cells was also measured by a modified Greiss
assay (Green et al., 1982) in order to establish the actual NO
concentration. These values were used to compare the present
results to published values. Briefly, a solution of 0.1% N-1-
naphthylenediamine and 1% sulfanilamide in 5% phosphoric acid
was combined with cell solutions at a ratio of 1:1/2 (vol/vol),
incubated for 10 minutes at room temperature in darkness, and
absorbance at 550 nM was measured. Sodium nitrite was used as a
standard.
Measurement of apoptosis
The effect of treatments on keratinocyte apoptosis was measured
with an ApoAlert Nitric oxide/Annexin V Dual Sensor kit (Clontech
Laboratories Inc.) according to the manufacturer’s instructions
(CLONTECHniques XVI, 1:24–25, 2001). In brief, cell pellets were
resuspended in 0.5 ml of Annexin V binding buffer and incubated at
room temperature for 30 minutes in the dark after gentle mixing. The
labeled cells were measured by flow cytometry.
Measurement of human iNOS and eNOS
iNOS and eNOS levels in hTERT cells were measured by
commercially available kits (R&D Systems DNS00) that employed
the quantitative sandwich enzyme immunoassay technique. Briefly,
hTERT cells were lysed and then pipetted into microplate wells pre-
coated with monoclonal antibody specific for iNOS or eNOS.
Unbound material was removed by rinsing, and an enzyme-linked
monoclonal antibody specific for iNOS or eNOS was added to the
wells and allowed to develop. The color development was stopped
and the intensity was measured at 450 nM.
Measurement of S-nitrosothiols levels
Keratinocyte S-nitrosothiol levels were determined by a fluorimetric
method (Marzinig et al., 1997; Massy et al., 2003). Briefly, culture
medium was removed after treatments as indicated in Results. Fifty
microliters of ammonium-sulfamate solution (0.1 mM) was then
added to the keratinocytes. To lyse cells, 100 ml of 1% Triton X-100
in HBSS without phenol red was added. After 10 minutes incubation
at room temperature, 50 ml of reaction mixture (one part of 1.1 mM
mercuric chloride and four parts of 0.05 g/l diaminonaphthalene in
0.62 M HCl) were added. The reaction mixture was incubated in the
dark at room temperature for 10 minutes, and then 10 ml of 2.8 M
NaOH was added to stop the reaction. Fluorescence intensity was
measure in a 96-well microplate at excitation and emission
wavelengths of 360 and 450 nm, respectively. The results were
compared to an S-nitrosothiol standard curve generated by a
standard prepared by adding reduced glutathione (GSH) (50 ml of
0.15–10.0mM GSH in 1 M HCl) to an equal volume of NaNO2 (10 mM)
at room temperature in darkness for 2 hours and then adding 50 ml of
100mM ammonium-sulfamate.
Measurement of cellular NOS activity
Measurement of NOS (e/cNOS, iNOS) activity present in
hTERT human keratinocytes was modified from that described
previously (Baudouin and Tachon, 1996). NOS activity was assayed
by measuring the conversion of [14C]L-arginine to [14C]L-citrulline.
Keratinocytes were treated with UVB, CGRP, and NOS inhibitors
at concentrations indicated in Results and assayed after either
30 or 60 minutes. Cells were harvested by scraping into ice-cold
HBSS containing 1 mM BH4, 1 mM dithiothreitol, 100 mM ethylene-
diame tetraacetic acid, 1mM leupeptin, and 1 mM pepstatin A.
All subsequent procedures were carried out at 41C. Cells were
sonicated for 20 seconds, then treated with HBSS containing
20 mM 3-[(3-cholamidopropyl) dimethylammonio]-1-propane sulfo-
nic acid (CHAPS) for 20 minutes on ice with gentle shaking.
Dowex AG 50W-X8 (Naþ form) was added to remove endogenous
arginine, mixed gently, and then centrifuged to remove the resin.
Cell lysate (250 mg protein in each reaction mixture) was incubated
in reaction buffer (pH 7.5) containing 50 mM Tris-HCl,
1 mM nicotinamide adenine dinucleotide phosphate, 15mM (6R)-
5,6,7,8-tetrahydrobiopterin, 5mM flavin adenine dinucleotide, 1 mM
ethyleneglycol-bis(b-aminoethyl ether)-N, N, N0, N0-tetraacetic acid,
3 mM CaCl2, 50 U/ml calmodulin, 5 mM L-arginine, and 15 mM
[U-14C]L-arginine at 371C for 30 minutes. The reaction was
terminated by diluting the sample in ice-cold stop buffer containing
20 mM N-2-hydroxyethylpiperazine-N0-2-ethanesulfonic acid, pH
5.5, 2 mM ethyleneglycol-bis(b-aminoethyl ether)-N, N, N0, N0-
tetraacetic acid, and 180 mg/ml Dowex AG 50W-X8 resin (Naþ
form). After gentle shaking and centrifugation, 200ml of the
supernatant was mixed with 10 ml of scintillation fluid and the
samples were counted.
Protein determination
Protein was measured according to the method of Bradford using
bovine serum albumin as a standard.
Statistical analysis
At least three independent experiments were performed for each
assay summarized in Results. All experimental conditions were
represented by duplicate or triplicate samples per independent
assay. The data sets were first analyzed by an F-test to determine that
the variances were the same in all groups, and where appropriate, an
analysis of variance to determine whether there was a significant
difference for time, treatment, and interactions. Means and standard
deviation (SD) values were calculated and comparisons between any
two groups were performed by the use of a standard Student’s t-test.
A value of Po0.05 was considered significant and a value of
Po0.001 was considered highly significant.
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